Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1419]

Genomic interrogation of tumour samples reveals essential targets

Dr Roland Eils - German Cancer Research Center (DKFZ), Heidelberg, Germany

Genomic interrogation of tumour samples reveals essential targets ( Dr Roland Eils - German Cancer Research Center (DKFZ), Heidelberg, Germany )

Implementing strategies to prevent cancer

Dr Graham Colditz - Washington University in St. Louis, St. Louis, USA

Implementing strategies to prevent cancer ( Dr Graham Colditz - Washington University in St. Louis, St. Louis, USA )

Reducing inequalities in global health risk

Prof Sir Michael Marmot - UCL Institute of Health Equity, London, UK

Reducing inequalities in global health risk ( Prof Sir Michael Marmot - UCL Institute of Health Equity, London, UK )

Results from the EURO-SKI cessation trial of TKIs in CML

Dr Johan Richter - Lund University, Lund, Sweden

Results from the EURO-SKI cessation trial of TKIs in CML ( Dr Johan Richter - Lund University, Lund, Sweden )

Safety and efficacy of imatinib generics

Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland

Safety and efficacy of imatinib generics ( Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland )

Proton beam therapy potential

Prof Gordon McVie - ecancer Founding Editor

Proton beam therapy potential ( Prof Gordon McVie - ecancer Founding Editor )

Ten years of letrozole improves survival and quality of life in early-diagnosed...

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA

Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin

Dr Hope Rugo - University of California, San Francisco, USA

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )

Randomised double blind phase III safety and efficacy trial of the proposed...

Dr Hope Rugo - University of California, San Francisco, USA

Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi

Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )

Radiotherapy in Hogkin lymphoma: reducing risk in later life

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Radiotherapy in Hogkin lymphoma: reducing risk in later life ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )

More from ecancer